Fda

129 results

“R&D is seriously expensive, and a lot of things tried don’t work out at the later stages after spending a huge amount of money.” Photograph: iStock

The need for new drugs and health products continues to rise while regulators, consumers and healthcare providers are demanding greater value for mone(...)

Vascepa is aiming to become the first prescription drug for people at risk of stroke or heart attack who continue to have high levels of harmful blood fats despite being on treatment with statins

Shares in US-listed Irish biotech Amarin surged in New York after it upgraded its profit forecasts. A strong update for the prospects of its cardiova(...)

Allergan: together with Abbvie, it  employs more than 2,300 people in Ireland.

Abbvie’s $63 billion approach for Allergan is just the latest episode in what can be a generally bewildering cycle of making and remaking of businesse(...)

Dependence is a  key concern around esketamine treatment. Urging caution and a need for public debate, a British expert observed that “we need to not let the genie get out of the bottle”

A new drug for treating depression has been approved in the US by the Federal Drug Administration (FDA). The same drug is now undergoing evaluation by(...)

The FDA grants priority review only to drugs that have the potential to offer significant improvement in the treatment of serious conditions.

Shares in Irish drug company Amarin jumped 14 per cent after its Vascepa drug was fast-tracked for approval as a treatment for reducing the risk of he(...)

Finlay McFadyen, head of investment banking, AIB Group; Fountain Healthcare partner Dr Manus Rogan; and Andrew McDowell, vice-president, European Investment Bank. Photograph: Nick Bradshaw

Irish life sciences venture capital group Fountain Healthcare Partners has raised €118 million in a new fund. The sum is well in excess of the €100 m(...)

Amarin chief executive John Thero: ‘Our guidance is for 50 per cent greater growth over the prior year’

Irish drug company Amarin will seek European approval for its cardiovascular drug Vascepa before the end of the year. The drug is in the process of s(...)

 Bill Gates at Trump Tower in New York. It  was during a  meeting between Gates and Trump in March of 2018 that the billionaire  claims he changed the president’s opinion on vaccinations.   Photograph:  Getty Images

How did Bill Gates manage to sway Donald Trump towards a pro-vaccination stance? By being there. There is a site where people share their favourite (...)

Reimbursement decisions in France and the UK led to revenue growth for one drug of 28.1 per cent in the first quarter of 2019 compared with a year earlier. Photograph: iStock

Irish pharmaceutical company Amryt said its revenues rose 13.3 per cent in 2018 to €14.5 million and the strong momentum continued into the first quar(...)

The New York Stock Exchange. Bank of America dipped 1.4 per cent ahead of results on Tuesday. Photograph:  Drew Angerer/Getty Images

European shares ended higher on Monday with telecom and retail stocks leading gains as Sino-US trade optimism and strong Chinese economic data eased s(...)

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next
  • Last »